Status:
COMPLETED
EF Intervention in Children With Severe Congenital Heart Disease
Lead Sponsor:
University Children's Hospital, Zurich
Conditions:
Heart Defects, Congenital
Executive Dysfunction
Eligibility:
All Genders
10-12 years
Phase:
NA
Brief Summary
Survival rates of children with severe congenital heart disease (CHD) have increased with ongoing medical progress over the past decades. However, many children with CHD face academic challenges durin...
Eligibility Criteria
Inclusion
- Born with CHD
- Underwent cardiopulmonary bypass surgery
- No genetic syndrome detected, no known dysmorphic-syndrome
- Aged 10 to 12
- written informed consent of parents and verbal informed consent of children
- EF deficits showing in screening
Exclusion
- Failure to provide a signed Informed Consent
- Heart surgery without cardiopulmonary bypass
- Heart surgery not performed in Switzerland
- Any genetic syndrome detected
- large cerebral lesions (stroke, HIE) or severely neurologically impaired as a result of a serious event
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05198583
Start Date
July 1 2022
End Date
August 14 2024
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8032